Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Short-term Investments: 2009-2024

Historic Short-term Investments for Pediatrix Medical (MD) over the last 16 years, with FY2024 value amounting to $118.6 million.

  • Pediatrix Medical's Short-term Investments rose 550.59% to $123.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $123.0 million, marking a year-over-year increase of 550.59%. This contributed to the annual value of $118.6 million for FY2024, which is 1347.66% up from last year.
  • Pediatrix Medical's Short-term Investments amounted to $118.6 million in FY2024, which was up 1347.66% from $104.5 million recorded in FY2023.
  • In the past 5 years, Pediatrix Medical's Short-term Investments registered a high of $118.6 million during FY2024, and its lowest value of $93.2 million during FY2022.
  • Its 5-year average for Short-term Investments is $104.2 million, with a median of $104.5 million in 2023.
  • In the last 5 years, Pediatrix Medical's Short-term Investments surged by 4074.62% in 2020 and then plummeted by 649.45% in 2022.
  • Annual analysis of 5 years shows Pediatrix Medical's Short-term Investments stood at $104.9 million in 2020, then decreased by 4.92% to $99.7 million in 2021, then fell by 6.49% to $93.2 million in 2022, then increased by 12.06% to $104.5 million in 2023, then increased by 13.48% to $118.6 million in 2024.
  • Its Short-term Investments stands at $118.6 million for FY2024, versus $104.5 million for FY2023 and $93.2 million for FY2022.